Chair: Gil Bashe, Chair, Global Health and Purpose, FINN Partners
9:15 AM
Gil Bashe, Chair, Global Health and Purpose, FINN Partners
TRACK
9:35 AM
Dr. Jerrold Jackson, Director, Partner Enablement, Mayo Clinic
Gil Bashe, Chair, Global Health and Purpose, FINN Partners
9:55 AM
Kyle Kaneicki, Vice President of Life Sciences and Healthcare, NYCEDC
10:15 AM
Sally Frank, Global Lead – Health & Life Sciences | Microsoft for Startups, Microsoft
Gil Bashe, Chair, Global Health and Purpose, FINN Partners
10:35
TRACK
11:00 AM
David Carey, Senior Partner, FINN Partners
11:20 AM
Pooja Majmudar, Investment Partner, Keles
Noosheen Hashemi, CEO & founder, January AI
Gil Bashe, Chair, Global Health and Purpose, FINN Partners
11:40 AM
Ruth Segall, Associate, WINDHAM Capital Partners
Isabelle Chae, Investor, DigiTx Partners
12:00 PM
Dr. Leighland Feinman, Medical Director, New Products and Innovation, US Vaccine Med Affairs, Sanofi
Dr. Terri Christene Phillips, Executive Director, Pediatric Infectious Diseases Society, PIDS Foundation
12:20 PM
TRACK
1:30 PM
Thomas Nichols, CEO & Founder, Pretika Medtech
1:50 PM
Dr. Jamie Wisser, Co-Founder, Board Chairman, CEO, Actual Healthcare Solutions
Robert Holton, President & COO, Actual Healthcare Solutions
2:10 PM
Dr. Joshua Tamayo-Sarver, MD, Vice President of Innovation at Vituity & Inflect Health
2:30 PM
Gregg Klang, CEO, Cern Corporation
2:50 PM
TRACK
3:30 PM
Jim Parshall, Executive Director – Drug Delivery R&D, Eli Lilly & Company
3:40 PM
Jim Parshall, Executive Director – Drug Delivery R&D, Eli Lilly & Company
Romain Marmot, President, Digital Health, Aptar
Julie Fishman, Advisor and Startup Board Member, formerly Global Head of Commercial at Astellas Pharma, RX+BA
4:00 PM
John Glaser, Program Director, Global Health Care Leaders, Harvard Medical School
4:20 PM
Gil Bashe, Chair, Global Health and Purpose, FINN Partners